Temanogrel (INN, USAN; developmental code name APD791) is a serotonin 5-HT2A receptor antagonist and inverse agonist which is under development for the treatment of myocardial ischemia and Raynaud's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.